Diabetes-induced Damage
Diabetes-induced Damage - Related Videos
04:09
Assessing DNA Damage Foci: To Identify Radiation-Induced DNA Damage Foci in Cancer Cell Line Using Immunofluorescence Staining
0 Views •
2023
This video describes a protocol to detect radiation-induced DNA repair foci in the colon cancer cell lines using immunofluorescence staining. DNA repair proteins get activated at the DNA damage site; therefore, we can detect them using specific antibodies and visualize them under a fluorescence microscope.
10:43
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
0 Views •
Cited by 98 •
2007
Our protocol was developed to cleanly and easily deliver islets or cells under the kidney capsule of mice. Cells are concentrated into pellets in the final tubing used for transplanting the cells under the kidney capsule. The ease of this technique reduces stress to the cells and the mouse.
03:50
Hematoxylin and Eosin Staining to Assess Colon Damage in DSS-Induced Colitis
0 Views •
2025
This video demonstrates the hematoxylin and eosin (H&E) staining method to evaluate colon damage in a murine model of DSS-induced colitis — an inflammatory bowel disease. Upon isolating the colon from a DSS-treated mouse and obtaining sections of the tissue, H&E staining of the sections helps identify the inflammation-mediated tissue damage.
06:43
Imaging Brain Damage Induced by Cerebral Hypoxia-Ischemia in a Mouse Model
0 Views •
2025
Source: Ouyang, Y., et al. Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia. J. Vis. Exp. (2015)This video demonstrates a technique to assess cerebral hypoxia injury via simultaneous positron-emission tomography (PET) and magnetic resonance imaging (MRI). An anesthetized mouse undergoes common carotid artery (CCA) ligation, reducing blood flow to one brain hemisphere and predisposing it to hypoxia-induced injury. PET and MRI imaging evaluate glucose metabolism and structural...
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
0 Views •
Cited by 2 •
2007
FAQs
Advanced glycation end products form when persistent hyperglycemia alters proteins and other biological structures. Their accumulation can disrupt normal tissue properties and contribute to vascular and cellular dysfunction. In diabetes-induced damage, this mechanism helps explain why prolonged glucose elevation can produce lasting injury even across different organs, supporting research into strategies that limit progressive structural change.
Oxidative stress and inflammation can reinforce the effects of chronically elevated blood glucose. Together, they place additional strain on cells and tissues while worsening functional impairment. This interaction is important because it connects a metabolic abnormality with progressive tissue injury, helping explain why diabetes-induced damage may extend beyond glucose-related changes alone and affect several organ systems.
Endothelial dysfunction impairs the normal performance of the cells lining blood vessels. Because these cells help maintain vascular function, their injury can contribute to problems affecting circulation and tissue support. Within diabetes-induced damage, endothelial dysfunction provides a mechanistic link to cardiovascular disease, kidney complications, impaired repair, and other outcomes associated with chronic vascular injury.
Different tissues respond to persistent hyperglycemia through distinct structural and functional vulnerabilities. The resulting injury may appear as diabetic nephropathy in the kidneys, retinopathy in the eyes, neuropathy in nerves, or impaired wound healing in damaged tissue. Considering these organ-specific manifestations helps clinicians recognize that diabetes-induced damage is a multisystem process rather than a single uniform complication.
Medical evaluation focuses on evidence of complications and loss of organ function rather than on glucose elevation alone. Clinicians assess manifestations such as diabetic nephropathy, retinopathy, neuropathy, cardiovascular disease, and impaired wound healing. This complication-oriented approach can support earlier detection, identify tissues at risk, and guide efforts to reduce further injury.
Studying these mechanisms supports risk reduction and the development of treatments intended to protect organ function and limit disease progression. The clinical value extends across kidney, eye, nerve, vascular, and wound-related complications. Connecting molecular processes such as glycation, oxidative stress, inflammation, and endothelial dysfunction with observable outcomes also helps organize research around earlier detection and targeted protection.